ASGCT News

Filter By

Recent Articles

Key Considerations of Gene Therapy Development: A Caregiver's Perspective

Emily Walsh Martin, PhD | June 22, 2022

Check back to our blog every week to learn more about Dr. Walsh Martin's journey and the emerging gene therapy efforts in syndromic and monogenic epilepsies.

Read Full Story

Sail for Epilepsy, Part 5: Realities of Selecting Clinical Dose Levels

Emily Walsh Martin, PhD | June 17, 2022

Check back to our blog every week to learn more about Dr. Walsh Martin's journey and the emerging gene therapy efforts in syndromic and monogenic epilepsies.

Read Full Story

The Gene Therapy Regulatory Landscape: Progress Made and Challenges Ahead

Adora Ndu, PharmD, JD | June 16, 2022

Adora Ndu, PharmD, JD, and her coauthors of a new Molecular Therapy piece share their perspectives on the role of PDUFA VII and discuss progress under the RMAT program and barriers to efficient clinical development.

Read Full Story

Lex Rovner Wants to Transform AAV Manufacturing

Nachi Pendse, PhD | June 02, 2022

Dr. Pendse talks to Lex Rovner, PhD, about her start in science and how she became co-founder and CEO of 64x Bio.

Read Full Story

Sail for Epilepsy, Part 4: Key Elements for Selecting a Proper Clinical Dose

Emily Walsh Martin, PhD | June 02, 2022

Check back to our blog every week to learn more about Dr. Walsh Martin's journey and the emerging gene therapy efforts in syndromic and monogenic epilepsies.

Read Full Story

Watch #ASGCT22 Sessions on Demand Through June 19

ASGCT Staff | June 01, 2022

Want to catch up on what you missed at the 25th Annual Meeting? Visit the virtual platform to watch plenary and education sessions, abstract presentations, and more.

Read Full Story

2022 Award Applications Now Open

ASGCT Staff | June 01, 2022

It's award season at ASGCT! Starting today, ASGCT members can apply for the following funded awards totaling close to $1 million.

Read Full Story

Sail For Epilepsy, Part 3: How Would Gene Therapy Work to Address Monogenic Epilepsies?

Emily Walsh Martin, PhD | May 27, 2022

Check back to our blog every week to learn more about Dr. Walsh Martin's journey and the emerging gene therapy efforts in syndromic and monogenic epilepsies.

Read Full Story

Catch the Final Plenary Speakers at #ASGCT22

ASGCT Staff | May 18, 2022

Today we'll hear from Don Kohn, MD, recipient of the Outstanding Achievement Award; Francis Collins, MD, PhD, recipient of the Founders Award; and Kathy High, MD, Presidential Symposium lecturer.

Read Full Story

#ASGCT22 Day Two: Learn From Our Award Recipients

ASGCT Staff | May 17, 2022

During our first plenary sessions of the week, recipients of the 2022 Annual Meeting Awards will present their research.

Read Full Story

Welcome to Day One of #ASGCT22!

ASGCT Staff | May 16, 2022

Stop by the Exhibit Hall today starting at 9:45 a.m. to chat with representatives from 170 companies. Later, interact with the first poster presenters during a networking reception in Hall D.

Read Full Story

Sail For Epilepsy, Part 2: An Overview of Syndromic and Monogenic Non-syndromic Epilepsies

Emily Walsh Martin, PhD | May 12, 2022

Check back to our blog every week to learn more about Dr. Walsh Martin's journey and the emerging gene therapy efforts in syndromic and monogenic epilepsies.

Read Full Story

Congratulations to Our Five New Board Members!

ASGCT Staff | May 10, 2022

Please welcome these new members of the ASGCT Board of Directors, who will take office on June 1!

Read Full Story

Download the #ASGCT22 Meeting App

ASGCT Staff | May 09, 2022

Start building your schedule and connecting with fellow meeting attendees in the app!

Read Full Story

A Worthy Excuse for Missing the ASGCT Annual Meeting

Emily Walsh Martin, PhD | May 04, 2022

Starting around May 14, Dr. Walsh Martin will join a five-person crew sailing nonstop for about 21 days from Florida to the Azores on Ingwe, a 50-foot catamaran, for Sail For Epilepsy. 

Check back to our blog every week to learn more about her journey and the emerging gene therapy efforts in syndromic and monogenic epilepsies.

Read Full Story

ASGCT and PlatformQ Health Partner to Deliver Continuing Medical Education

ASGCT Staff | May 03, 2022

The partnership with PlatformQ Health, a digital technology and education company, will help clinicians stay ahead of new therapeutic options for patients.

Read Full Story
2022

ASGCT Policy Summit

September 26-27, 2022

This site uses cookies to offer you a better user experience and to analyze site traffic. By continuing to use this website, you accept our use of cookies.